rs1539243 — IKBKE IKBKE Ile67 synonymous variant

Synonymous coding variant in exon 4 of IKBKE (IKK-epsilon); the C allele tags an IKBKE haplotype associated with increased SLE susceptibility, and has been implicated in antiviral innate immunity

See your personal result for IKBKE

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

IKBKE — When the Innate Immune Alarm Misfires

The IKBKE gene11 IKBKE gene
Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Epsilon, located at chromosome 1q32.1, encoding the IKKε kinase — a central switch in innate antiviral immunity and inflammatory signalling plays a dual role in human immunity that has made it one of the more interesting targets in autoimmune genetics. When a virus enters the body and triggers innate immune sensors, IKKε is one of the kinases that phosphorylates IRF3 and IRF7 — the transcription factors responsible for producing type I interferons (IFN-α/β), the body's frontline antiviral broadcast. The same enzyme also activates NF-κB, the master regulator of inflammatory gene expression. Get the balance right and you clear a virus efficiently. Let IKKε run unchecked and you drive excessive type I interferon production — one of the hallmarks of systemic lupus erythematosus (SLE).

rs1539243 sits in exon 4 of IKBKE and is a synonymous coding variant: the C and T alleles both encode isoleucine at codon 67 (Ile67), leaving the protein sequence unchanged.

The Mechanism

IKKε (encoded by IKBKE) is a noncanonical IκB kinase related to TBK1. Its canonical role is phosphorylating IRF3 and IRF722 phosphorylating IRF3 and IRF7
Interferon regulatory factors 3 and 7 — nuclear transcription factors that, once phosphorylated by IKKε or TBK1, dimerize and translocate to the nucleus to drive IFN-β and IFN-α gene transcription. This phosphorylation occurs downstream of Toll-like receptors (TLR3, TLR4), RIG-I/MDA5 viral RNA sensors, and STING. Alongside IRF activation, IKKε phosphorylates IκBα to release and activate NF-κB, amplifying a broader pro-inflammatory gene program including TNF, IL-6, and CXCL chemokines.

The Evidence

The case for IKBKE as an SLE susceptibility gene rests on a study by Gateva et al. 201133 Gateva et al. 2011
"A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE", screened 78 interferon pathway genes across 2,136 SLE cases and 9,694 controls (Swedish and US cohorts). rs1539243 (C allele) emerged with OR 1.19 (95% CI 1.09–1.31, P=0.00026) in the combined meta-analysis — a modest but robustly replicated risk effect.

The rs1539243 C allele has also been reported in a study of symptomatic dengue in Colombian children44 a study of symptomatic dengue in Colombian children
Ramirez et al. 2018, Viral Immunology, where IKBKE haplotypes were associated with resistance to symptomatic dengue — consistent with IKKε's role in antiviral innate immunity. The same genetic architecture that modestly increases autoimmune risk may confer benefit in certain infectious disease contexts, illustrating the evolutionary trade-off common to immune regulatory genes.

The evidence level is moderate: IKBKE association with SLE has been independently replicated, the biological mechanism is coherent, but the individual SNP effect is modest (OR ~1.19) and no CPIC/DPWG or clinical actionability guidelines exist.

Practical Actions

For carriers of the CC or CT genotype, the primary implication is awareness of elevated SLE susceptibility and vigilance for early autoimmune symptoms. SLE is more common in women (9:1 ratio) and in people of African, Asian, and Hispanic descent, so this variant should be interpreted in the context of other SLE risk factors. The IKBKE variant alone does not predict SLE — it modestly increases background risk as one of many genetic inputs.

Practically, supporting innate immune regulation through established lifestyle factors (adequate sleep, omega-3 fatty acids for anti-inflammatory signalling) is relevant for anyone with elevated SLE susceptibility, though the specific value of each measure for IKBKE carriers has not been studied in trials.

Interactions

Within the type I interferon pathway, IKBKE works in concert with TBK1 (which has overlapping kinase substrates) and IRF5, IRF7, and STAT4 — all of which have independently replicated SLE GWAS associations. Convergence of risk alleles across multiple interferon pathway genes substantially increases cumulative SLE risk beyond any single variant.

Genotype Interpretations

What each possible genotype means for this variant.

TT Protective Genotype Beneficial

Lower SLE-associated haplotype burden — the protective IKBKE genotype

The TT genotype places you in the small fraction of people carrying no copies of the IKBKE risk haplotype. In the candidate gene study of 2,136 SLE cases and 9,694 controls, the C allele (which you lack) conferred OR 1.19 per allele for SLE risk. Absence of both C alleles does not eliminate SLE risk — SLE is polygenic with 100+ associated loci — but does mean this particular interferon-pathway input is not contributing elevated risk.

The IKBKE gene encodes IKKε, a kinase that phosphorylates IRF3 and IRF7 to drive type I interferon production and also activates NF-κB. Appropriate IKKε activity is essential for antiviral innate immunity.

CT Heterozygous Carrier Intermediate

One copy of the IKBKE SLE risk allele — modest increase in type I interferon pathway susceptibility

The association between IKBKE variants and panic disorder has been reported in a smaller study (OR 1.50 for PD, but did not survive multiple testing correction), suggesting possible neuroinflammatory pathways — but this finding should be considered exploratory and not grounds for clinical action.

CC Homozygous Risk High Risk

Homozygous IKBKE risk genotype — elevated type I interferon pathway susceptibility, increased SLE risk

The CC genotype is also the genotype that, paradoxically, is associated with resistance to certain viral conditions in other ethnic populations: Colombian children carrying IKBKE C-haplotypes showed lower rates of symptomatic dengue, illustrating the evolutionary trade-off between autoimmune susceptibility and infectious disease resistance that characterises many immune regulatory loci.

SLE is polygenic and the OR of 1.19 per C allele (or ~1.42 for CC vs TT using additive model) is a modest risk increment. However, when the CC genotype co-occurs with other SLE-associated variants in IRF5, STAT4, IRF7, or PTPN22, the cumulative risk becomes clinically meaningful.